Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8702 |
High Similarity |
NPD422 |
Phase 1 |
0.8582 |
High Similarity |
NPD2797 |
Approved |
0.854 |
High Similarity |
NPD3268 |
Approved |
0.8531 |
High Similarity |
NPD3750 |
Approved |
0.8406 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8273 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8227 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8227 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8182 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8176 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8175 |
Intermediate Similarity |
NPD3266 |
Approved |
0.8175 |
Intermediate Similarity |
NPD3267 |
Approved |
0.8138 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8054 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7971 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7959 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7945 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7891 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7872 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7867 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7857 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7838 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD920 |
Approved |
0.7826 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7815 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7815 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7815 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7808 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7793 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7792 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.777 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7762 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7756 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7755 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7754 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7724 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7721 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7718 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7703 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7703 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7698 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7697 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7639 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7626 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.761 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7595 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7547 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7546 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3226 |
Approved |
0.75 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7483 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7482 |
Intermediate Similarity |
NPD17 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD37 |
Approved |
0.7467 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7467 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7438 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7438 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7407 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7397 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7365 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7361 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7353 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7321 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.729 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD411 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7256 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD919 |
Approved |
0.7235 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7234 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD2370 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7212 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7211 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7194 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD940 |
Approved |
0.7176 |
Intermediate Similarity |
NPD846 |
Approved |
0.7172 |
Intermediate Similarity |
NPD6362 |
Approved |
0.7171 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7171 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7472 |
Approved |
0.716 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7103 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.709 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD2354 |
Approved |
0.705 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7042 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7039 |
Intermediate Similarity |
NPD5689 |
Approved |
0.7039 |
Intermediate Similarity |
NPD5688 |
Approved |
0.7035
|
Intermediate Similarity |
NPD7549 |
Discontinued |